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Retrograde mesenteric stenting during laparotomy
for acute occlusive mesenteric ischemia
Mark C. Wyers, MD, Richard J. Powell, MD, Brian W. Nolan, MD, and
Jack L. Cronenwett, MD, Lebanon, NH
Introduction: Acute mesenteric ischemia (AMI) caused by arterial occlusive disease requires prompt diagnosis and
revascularization to avoid the high mortality associated with this disease. In an attempt to minimize the magnitude of
operation for arterial occlusive AMI, we have developed a new technique of endovascular recanalization and open
retrograde stenting of the superior mesenteric artery (SMA) during laparotomy so that the bowel can also be assessed and
resected if necessary.
Methods: All emergent mesenteric revascularizations for arterial occlusive AMI performed at Dartmouth-Hitchcock
Medical Center from 2001 to 2005 (n  13) were retrospectively reviewed. Outcomes were analyzed with respect to the
method of revascularization and other perioperative variables. Restenosis was evaluated with duplex ultrasound imaging.
Results: Three different revascularization methods were used: surgical bypass (n  5), antegrade percutaneous stenting
(n  2), and retrograde open mesenteric (SMA) stenting (ROMS, n  6). Satisfactory revascularization was achieved in
all cases and all methods. ROMS was successfully accomplished in three of six patients after antegrade attempts to cross
the SMA from the arm were unsuccessful. At 17%, the ROMS group had the lowest hospital mortality compared with
bypass at 80% (P  .08) and percutaneous stent at 100% (P  .11). All five of the surviving patients treated with ROMS
were discharged to home after a mean hospital stay of 20 days (range, 6 to 38 days). During a mean follow-up of 13 
7 months, three patients died of unrelated causes, of which two were being followed with asymptomatic recurrent SMA
stenosis detected by duplex scan. The two surviving patients are alive and well, but one has required percutaneous SMA
stenting of a progressive asymptomatic restenosis.
Conclusion: Retrograde open SMA stenting during laparotomy for AMI has a high technical success rate and provides an
attractive alternative to surgical bypass in these often critically ill patients. Because it is combined with open laparotomy,
it honors the essential surgical principles of evaluating and resecting nonviable bowel. Restenosis rates appear to be high,
so that patients must be followed closely. Further study and development of this new hybrid technique is warranted.
(J Vasc Surg 2007;45:269-75.)Acutemesenteric ischemia (AMI) caused by atheroscle-
rotic occlusive disease has traditionally been treated with
emergent operative bypass, often combined with segmental
resection of nonviable small bowel. The reported mortality
rate for these patients varies from 75% to 100%.1,2 Endo-
vascular treatment for chronic mesenteric ischemia has
been well described for subacute presentations, especially in
patients at high operative risk or as a bridge to a more
elective surgical bypass after the acute illness has re-
solved.1,3-7
Endovascular treatment has not, however, generally
been applied to patients with AMI who need emergent
revascularization and potential resection of nonviable
bowel. This is because such a percutaneous procedure does
not allow for an assessment of bowel viability, requires
advanced endovascular skills, and even in the most experi-
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doi:10.1016/j.jvs.2006.10.047enced hands, can take substantial time that might delay
revascularization.
Retrograde open mesenteric stenting (ROMS) is a
hybrid technique, similar to that described by Milner et al8
in a 2004 case report, that combines open surgical and
endovascular approaches. Previously unaware of this re-
port, we developed our variation of this technique contem-
poraneously and first performed it in 2002.
In this approach, the SMA is exposed at the base of the
transverse mesocolon for retrograde cannulation after local
patch angioplasty at the intended puncture site. Like tradi-
tional surgical bypass, this approach allows for an accurate
assessment and treatment of any nonviable bowel during
laparotomy. At the same time, stenting of the superior
mesenteric artery (SMA) is performed to revascularize the
viscera. Cannulation through the infracolic SMA offers the
potential advantage of a more direct approach to lesions
that might otherwise require arm or prolonged femoral
access. This report presents our early experience with this
approach in a select group of patients with occlusive AMI
who required emergent revascularization.
PATIENTS AND METHODS
We reviewed all patients who underwent emergent
mesenteric revascularization for arterial occlusive AMI
from 2001 to 2005. Patients with embolic mesenteric
occlusions were excluded, and only the subset of patients
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ischemia that required emergent treatment was analyzed. A
retrospective review was then performed of 14 patients who
met these criteria. One of these patients was excluded from
analysis because the revascularization was abandoned ow-
ing to total necrosis of the small bowel found at laparot-
omy. Of the 13 remaining patients, five were treated with a
traditional open surgical bypass, two were treated with
antegrade percutaneous SMA stenting, and the remaining
six were treated with ROMS.
Patient selection into the different treatment groups in
this small series was essentially chronologic and mirrors the
evolution of our endovascular experience with mesenteric
interventions. The first five patients were treated with by-
pass because this predated our experience even with elective
mesenteric stenting. As our experience with percutaneous
mesenteric stents increased, we began to consider this
application for more urgent indications.
Percutaneous attempts at recanalization of the oc-
cluded SMA proved to be very time consuming, and in this
patient population, the need for bowel exploration could
not be avoided. As such, the two patients who were treated
with antegrade percutaneous SMA stenting represent a
transition to the more recent development of the ROMS
technique. Emergent percutaneous revascularization in our
practice has been replaced by ROMS when the abdomen
must be explored to determine bowel viability. The first
retrograde mesenteric stent implantations were performed
in patients with peritoneal soilage and no apparent saphe-
nous conduit or with calcified, infrarenal inflow vessels that
could not be clamped for retrograde bypass. Subsequently,
as a result of good outcomes, this has become our preferred
approach.
Surviving patients were followed-up clinically and un-
derwent periodic mesenteric duplex evaluation. The same
duplex protocol used for the identification of primary SMA
Table I. Preoperative patient variables
Patient Year Age Gender Time to
Surgical bypass
JC 2003 67 M
EO 2001 86 F
GJ 2003 60 M
MM 2002 39 F
LC 2002 66 F
Percutaneous antegrade stent
DK 2002 71 F
EW 2001 64 F
Retrograde SMA stent
RS 2002 60 M
HE 2005 66 F
VG 2004 67 F
IM 2004 68 F
LW 2004 62 F
RG 2005 52 M
WBC, White blood cells; OR, operation; MRA, magnetic resonance angiogstenosis was used to detect recurrent stenoses; this has beenpreviously published.9 Briefly, our diagnostic criteria for a
50% SMA stenosis include a fasting peak systolic velocity
(PSV) 300 cm/s and an end-diastolic velocity (EDV)
45 cm/s. Repeat angiography was performed in medi-
cally suitable patients at the surgeon’s discretion when a
restenosis was identified by duplex or when recurrent symp-
toms prompted such intervention.
Statistical analysis was limited by the small numbers of
patients. Fisher’s exact testing was used where appropriate
to determine significance between proportions, and analy-
sis of variance was used for continuous variables.
Retrograde open mesenteric stent technique. A pa-
tient with suspected AMI on clinical grounds or from
preoperative imaging (Table I) is brought directly to the
operating room while resuscitation is ongoing. With the
patient supine, the left arm is abducted and also undergoes
sterile preparation in the event that brachial access is re-
quired. Depending on the degree of preoperative evalua-
tion, a diagnostic arteriogram may be obtained initially
through a brachial or femoral approach. Once the diagnosis
is confirmed, the abdomen is explored by using a midline
laparotomy.
The infracolic SMA is exposed and controlled inferior
to the transverse colon mesentery. At this point, the patient
is fully heparinized, and the activated clotting time is main-
tained at 300 seconds until the revascularization is com-
plete. The artery is incised longitudinally, and a local
thromboendarterectomy is performed if necessary. A patch
angioplasty of the SMA is performed to facilitate the next
portion of the procedure. We most commonly use a bovine
pericardial patch (Vascu-Guard, Synovis, St Paul, MN), but
a saphenous vein patch can also be used if the peritoneal
soilage is significant. The patch can be further protected by
closure of the peritoneum over the site of the SMA explo-
ration.
A 6F, 35-cm-long flexible sheath (Arrow International
(hours) WBC (1000s) Acidosis Imaging
17.2 Y Angio
3.7 Y MRA
3.8 Y CT
17.1 N CT
10.5 Y Angio, CT
31 N CT
19.5 Y Plain x-ray
10.4 Y Angio, CT
21.2 Y Duplex
1.1 N Angio
14.9 Y CT
28.4 N CT
32 N CT
; CT, computed tomography; SMA, superior mesenteric artery.OR
24
12
96
12
30
48
24
48
24
3
48
36
72Inc, Reading, PA) is then placed into the SMA in retro-
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to place the working sheath through the patch rather than
through an open arteriotomy to facilitate angiographic
evaluation of the distal mesenteric arcade before and imme-
diately after restoration of antegrade flow. A purse string
suture can be placed in the patch before its puncture to
facilitate sheath removal without having to reclamp the
SMA. The longer-length working sheath here is important
so that during fluoroscopy the surgeon can work comfort-
ably, out of the wound and away from the image intensifier.
Once the sheath is in place, all metallic abdominal
retractors are removed and the surgeon performs hand-
injected retrograde, lateral angiography (Fig 1). This is
used as a roadmap to cross the SMA stenosis or occlusion.
A simultaneous flush aortography using a femoral or bra-
chial catheter can also be done to provide a re-entry target
and to confirm anatomic landmarks.
A 0.035-inch glidewire (Terumo, Somerset, NJ) is
typically used to cross the lesion luminally or subadventi-
tially if necessary. The 0.035-inch glidewire is then catheter
exchanged in favor of a lower-profile 0.018-inch or 0.014-
inch platform. The lesion usually requires predilation
with a 2-mm or 3-mm angioplasty balloon and then is
retrograde stented with a 5-mm to 7-mm low-profile
balloon-expandable stent (Fig 2), with the proximal-
Fig 1. Retrograde superior mesenteric artery (SMA) injection.
Note the proximity of the sheath’s point of entry (black arrow) and
of the sheath’s tip (white arrow) to the proximal SMA occlusion.
There is no reflux of contrast into the aorta.most stent allowed to protrude 1 mm to 2 mm into theaortic lumen. Frequently, more than one stent is re-
quired to cover these lesions, which are typically 2 cm to
3 cm in length (Fig 2, A ).
Before the sheath is removed, completion arteriogra-
phy is performed in both anteroposterior and lateral pro-
jections (Fig 2, B), and pressure measurements are per-
formed across the stented region to confirm that there is no
residual pressure gradient. An anteroposterior arteriogra-
phy can also be performed to see the full mesenteric arcade
and evaluate collateral supply to the foregut. The sheath
puncture site in the patch is repaired. Any perforated or
severely necrotic bowel that is likely to perforate is expedi-
tiously resected with a gastrointestinal stapler, but final
assessment of bowel viability and advisability of reanasto-
mosis maybe delayed until a second-look procedure is
Fig 2. A, Intraoperative lateral fluoroscopic image shows two
stents (underscored by a white line) deployed in the superior
mesenteric artery (SMA) origin with the 0.018-inch wire still in
place. Note the lumbar vertebral bodies to the left. B, Completion
retrograde arteriogram shows free reflux of contrast into the aorta
and no residual angiographic stenosis; P denotes the approximate
location of the SMA patch angioplasty.performed in 24 to 48 hours.
enteri
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Patient and preoperative variables are recorded in Table I.
The amount of time between the onset of constant abdom-
inal pain or tenderness was estimated from the medical
record to determine if an inordinate delay in diagnosis or
treatment occurred in any patient. The average preopera-
tive time delay to operation for the bypass, percutaneous
stent, and ROMS groups was 35, 36, and 38 hours, respec-
tively. Total duration of the operative procedure including
adjunctive bowel resection averaged amean SD of 332
67 minutes for bypass, 329  46 for percutaneous stent,
and 281  21 minutes for ROMS (P  .45; Table II).
Preoperative white blood cell counts were either
abnormally high (10,000) or low (4000) in all pa-
tients (Table I). Acidosis was defined as pH 7.3, serum
bicarbonate 18 mmol/L or elevated serum L-lactate
levels and was not different between groups (P  .54).
Preoperative imaging consisted of computed tomogra-
phy (CT) in 8, angiography separate from the index revas-
cularization procedure in 4, magnetic resonance angiogra-
phy (MRA) in 1, duplex ultrasound imaging in 1, and plain
abdominal radiographs in 1. Among the 8 patients who
underwent preoperative CT scanning, the study was con-
sidered diagnostic of AMI in four patients and strongly
supportive of the diagnosis in the remaining four.
Surgical bypasses were performed to the SMA only and
satisfactorily revascularized the intestine in all five cases.
Two were preformed in antegrade fashion from the su-
Table II. Perioperative results
Patient
Bowel
necrosis Revascularization
Duration
(min)
Outco
(POD
Surgical bypass
Conduit/inflow source
JC No PTFE/Iliac 584 Death (
EO Yes Vein/supraceliac Aorta 320 Death (
GJ Yes Vein/iliac 283 Death (
MM Yes PTFE/supraceliac Aorta 289 Home
LC Yes Vein/iliac 186 Death (
Percutaneous antegrade stent
No. stents/diameter
DK Yes 2/5 mm 283 Death (
EW Yes 3/6 mm 375 Death (
Retrograde SMA stent
No. stents/diameter
RS Yes 2/6 273 Death (
HE No 2/7 mm 260 Home
VG No 2/6 mm 194 Home
IM Yes 2/7 mm 348 Home
LW No 2/6 mm 315 Home
RG Yes 1/7 mm 298 Home
POD, Postoperative day; PTFE, polytetrafluoroethylene; SMA, superior mespraceliac aorta: one because of extreme calcification of theiliacs and infrarenal aorta that rendered those inflow arteries
unclampable, and the other because of aneurysmal infrare-
nal aorta and iliac segments. Three bypasses were oriented
in retrograde fashion using an iliac artery as the inflow
source. One donor iliac artery required endarterectomy and
another required repair of a clamp injury before construc-
tion of the bypass.
Vein grafts, when used (Table II), were the great (n 
2) or anterior saphenous (n  1) vein. The saphenous was
the intended conduit for a fourth patient but was found to
be inadequate for bypass. A kinked vein graft resulted in
one early graft failure in the retrograde bypass group, and
this patient did not survive because of complications of
bowel infarction associated with the graft occlusion.
There were no prosthetic graft infections despite the
eventual requirement for bowel resection owing to necrosis
in both patients in whom these grafts were used. Two
patients in the bypass group required bowel resection at the
initial operation, and all patients required a subsequent
second-look operative reassessment and eventual resection
of nonviable bowel. In-hospital mortality for this group was
80%. Three of four deaths were associated with multisys-
tem organ failure as a consequence of the AMI, and the
fourth death was due to bowel necrosis after bypass graft
occlusion.
Two patients had successful percutaneous SMA stent-
ing: one to treat a severe stenosis and the other to recanalize
an occluded SMA (Table II). The patient with the SMA
Adjunctive procedures
Second look POD 3
Resection ischemic ileum, second look POD 1
Second look POD 1, resection necrotic ileum
Failed perc stent attempt. Subtotal colectomy, cholecystectomy,
resection ileum, second look POD 2
Acute thrombosis of SMA stent, resection of ileum. Second
look POD 2, graft thrombosis
Subtotal colectomy
Ileum resection. Second look. POD 1, small bowel appeared
ischemic? Low flow.
Failed perc stent attempt, second look POD 1; R
hemicolectomy, developed R leg ischemia; AKA.
Previous celiac stent; failed previous SMA stent for CMI.
Second look POD 3
Failed perc stent attempt by interventional radiology
immediately before to exploration.
Failed perc stent attempt, Small bowel resection
Failed perc stent attempt
Subtotal colectomy
c artery; AKA, above knee amputation; CMI, chronic mesenteric ischemia.me
)
59)
3)
13)
(40)
2)
6)
1)
25)
(27)
(38)
(22)
(6)
(8)occlusion then required open SMA endarterectomy with
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because of diffuse occlusive disease. Stent diameters are
listed in Table II. The initial plan to evaluate the intestine
laparoscopically in these two percutaneously treated pa-
tients was abandoned in favor of operative exploration in
one patient because of this need to endarterectomize the
distal SMA and in the other because of inadequate visual-
ization with the laparoscope. Both patients required bowel
resection after the revascularization was complete. Both
patients died within a week of their initial operation, one
from multiple system organ failure and the second from
bowel necrosis that occurred after stent thrombosis.
ROMS was performed as described in six patients with
SMA occlusions and was technically successful in all pa-
tients (Table II). In five, a prior attempt at antegrade SMA
stenting through a brachial approach was unsuccessful (3
during this index procedure, and 2 previously during a
separate attempt at SMA stenting). Two retrograde stents,
each about 18 or 19 mm long, were required for each SMA
and were either 6 or 7 mm in diameter, for a mean ex-
panded diameter of 6.4 mm. The incidence of bowel ne-
crosis in this retrograde stent group was 50%.
Although we maintain a low threshold for second-look
operations, only two patients required a second-look lapa-
rotomy to evaluate bowel viability. The need for a second
look is assessed daily by both general and vascular surgery
services and is strongly influenced by the patient’s overall
condition as well as specific variables such as acidosis, white
blood cell count, return of bowel function, and abdominal
exam.
This apparently reduced incidence of bowel infarction
did not, however, reach statistical significance when com-
pared with the other groups (P  .18 vs open revascular-
ization; P  .46 vs percutaneous group). The cause of the
single death in this group wasmultiple system organ failure.
Despite the small numbers, in-hospital mortality was signif-
icantly lower in this ROMS group at 17% compared with
the 80% in the bypass group (P .08) and 100% (P .11)
in the percutaneous stent group.
Five of six patients in the retrograde stent group sur-
vived and were discharged to home (Table III) after a mean
hospital stay of 20 days (range, 6 to 38 days). One of those
five died suddenly and unexpectedly at home 1 month after
her retrograde stent procedure. An autopsy was not per-
formed, but this patient had a known 7-cm thoracoab-
dominal aneurysm, and given the rapidity of her death, this
Table III. Follow-up of surviving retrograde stent patient
Patient
Follow-up
(months) Restenosis Symptomatic
PSV/EDV
(cm/sec) Secon
HE 10 Yes No 321/67 Reste
VG 20.2 Yes No 399/159 None
IM 1 NA NA NA
LW 16.5 Yes No 409/103 None
RG 4.5 No No 195/32 Angio
PSV, Peak systolic velocity; EDV, end-diastolic velocity; NA, not applicablewas presumed to be the actual cause.The four remaining retrograde stent patients have been
followed-up for a mean of 13  7 months (Table III),
and two have subsequently died. One patient (VG) was
followed-up closely with a recurrent, asymptomatic steno-
sis until her death from acute myelogenous leukemia 20
months after her mesenteric revascularization. Another late
death occurred at home in a very debilitated patient (LW)
16 months’ postoperatively. She had no abdominal symp-
toms, but a variety of other medical comorbidities and was
being followed up by duplex imaging for a progressive,
severe in-stent restenosis. No autopsy was performed.
The two remaining patients are asymptomatic and both
have had repeat outpatient arteriograms approximately 4
months postoperatively. One (HE) was found to have a
recurrent, asymptomatic stenosis on duplex that was suc-
cessfully treated with additional stents placed percutane-
ously. The restenosis has not recurred in the interval 6
months. The second patient (RG) underwent selective
mesenteric arteriography for screening as part of another
peripheral percutaneous intervention for claudication and
there is no recurrent mesenteric stenosis.
DISCUSSION
Acute thrombo-occlusive mesenteric ischemia requires
prompt diagnosis to avoid bowel necrosis and the incum-
bent morbidity and mortality. Confirmatory diagnosis with
conventional arteriography or, increasingly, with high res-
olution CT angiography (CTA)10-13 performed early in the
patient’s presentation is critical to reduce the incidence of
ischemic bowel.
In the emergent setting, retrograde bypass to the SMA
with vein or synthetic conduit is arguably the most com-
monly performed procedure. Antegrade bypass from the
supraceliac aorta to one or both mesenteric vessels is ideally
reserved for elective bypass in more stable patients because
it is more physiologically stressful.14 A less invasive option
for SMA revascularization in these critically ill patients is
theoretically appealing. Whichever revascularization strat-
egy is followed, however, the general surgical principles of
thorough abdominal exploration, sepsis control, and a low
threshold for second-look operations must be honored to
increase chances for a favorable outcome.
The ROMS technique allows confirmatory angiogra-
phy to be followed immediately by definitive revasculariza-
tion in the same operative setting. We believe that ROMS,
in carefully selected patients, is a promising new hybrid
procedure Comment
.2 mo Alive, asymptomatic
Died of acute myelogenous leukemia, 20 mo post-op
Died of presumed AAA rupture, 1 mo post-op
Died of unknown cause, 16 mo post-op
, 4.5 mo Alive, asymptomatics
dary
nt, 4
—
onlyprocedure that provides an efficient, less-invasive mesen-
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general surgical principles. As was seen in this small series,
donor vessel problems, such as abdominal aortic aneurysm
or severe aortic or iliac calcification, can complicate an
operative bypass or potentially force the need for the more
complex antegrade bypass. ROMS avoids aortic clamping
as well as potential difficulty with aortic or iliac artery
quality.
ROMS can also avoid the issue of prosthetic conduit in
a field that is often contaminated by using only a small
bovine pericardial patch or a vein patch.We have found that
patch angioplasty of the SMA and puncture of the patch,
rather than direct SMA puncture, avoids inadvertent artery
injury and assures lack of disease at the puncture site by
allowing local endarterectomy if needed. Endarterectomy
was required in only one patient in the ROMS group
because of a focal plaque that involved the anterior wall of
the artery that could not be treated with patch angioplasty
alone. Thrombus volume was usually small and was usually
limited to the retropancreatic portion of the SMA, above
any of the proximal SMA branches. Fogarty embolectomy
should be considered, but was not usually required of the
distal SMA.
In addition, placement of the working sheath through
the SMA patch is secure while still allowing for some runoff
through the distal mesenteric arcade. This greatly facilitates
angiography and allows pressure measurements across the
SMA stents. If a pursestring suture is placed before patch
puncture, the sheath can be removed without reclamping
the diseased SMA in proximity to the newly placed stents
and with no further ischemia time.
Because of the multiple adjunctive procedures of bowel
resection, cholecystectomy, and operative diagnostic arte-
riography, it was not possible to accurately compare the
time required for revascularization in these small sub-
groups. The mean operative time in the ROMS group
would likely have been shorter were it not for a failed
attempt at percutaneous stent placement before retrograde
placement in three of six patients (Table II). We no longer
make any percutaneous attempt in patients who present
with AMI.
It is our impression that ROMS is as fast or faster than
an uncomplicated retrograde bypass with synthetic con-
duit. It is likely faster than a vein bypass because it elimi-
nates the search for, harvest of, and preparation of conduit.
In at least one patient in the bypass group, vein harvest was
attempted before it was judged to be inadequate, which
required the use of prosthetic conduit and further delayed
revascularization. ROMS also avoids the potential kinking
problems of vein bypass in a retrograde fashion to the SMA,
which we experienced in one of our patients.
Percutaneous endovascular treatment of acute mesen-
teric occlusions combined with laparoscopy to assess bowel
viability has been reported.15,16 Diagnostic laparoscopy for
this indication has not been widely accepted17 because it
may miss areas of nonviable bowel. Furthermore, the tech-
nical success rate with percutaneous recanalization of oc-
cluded mesenteric arteries is lower than the 100% technicalsuccess rate reported here in our early experience with
ROMS. In fact, five of the six patients successfully treated
by ROMS underwent previous unsuccessful attempts at
antegrade treatment of their SMA occlusion (Table II).
Three of these previous attempts were performed in the
operating room immediately before the ROMS procedure
and additionally may have caused some overestimation of
the operative time required for ROMS.
We believe that this higher technical success rate is due
to superior pushability and torquability achieved by direct
SMA access close to the point of obstruction. In addition,
we have had no difficulty with re-entry into the abdominal
aorta when subintimal passage of the wire occurs. For
longer SMA lesions, ROMS also allows local endarterec-
tomy to increase flow distally. Retrograde stenting also
allows for protection against distal embolization, both
atheroemboli and thromboemboli, which may occur dur-
ing attempts at crossing the occlusion antegrade. In our
practice, we now reserve percutaneous mesenteric stenting
for patients with chronic or subacute presentations who do
not require a detailed assessment of bowel viability.
Although we have only compared a small number of
patients, we observed a strong trend towards a lower in-
hospital mortality rate in the ROMS group. An equally
efficacious procedure with less associated physiologic stress
is appealing, but we cannot be certain from this initial
experience that improved survival is a result of this tech-
nique. The improved survival may be the result of earlier
diagnosis and better preoperative imaging with multidetec-
tor CTA. The difference in time to operation was not
different between the groups, but there was a trend toward
less frequent bowel resection in the ROMS group. This
may be the better surrogate marker for delay in diagnosis
and explain the results in such a small, highly selected group
of patients. The retrospective, highly selected nature of this
small case series constitutes the main weakness of such a
report. Larger numbers of patients, followed up prospec-
tively, would be necessary to determine the potential im-
pact of this technique on morbidity and mortality rates.
The main limitation with mesenteric stenting in gen-
eral, which we and others have reported,4,18-20 is the high
rate of recurrent stenosis. Restenosis rates may be even
higher in these patients because of the longer lesion length
associated with complete occlusions. Frequent duplex sur-
veillance is required to judge the need for reintervention.
Recurrent stenosis seems to happen relatively early after
mesenteric stenting,4 so we recommend surveillance within
the first month and every 3 months thereafter.
Most patients can be retreated with a percutaneous
approach as outpatients. Many of these patients remain
poor operative candidates and have limited life expectancies
because of other comorbidites,14 and in this situation, even
repeated SMA dilatations are a viable, safe option. For
patients who make a good recovery and are nutritionally
sound, ROMS, like percutaneous stenting for chronic mes-
enteric ischemia, may serve as a bridge to a more durable
operative bypass.5 In the near future however, balloon-
JOURNAL OF VASCULAR SURGERY
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stents may be useful to reduce the problem of restenosis.
CONCLUSION
We believe that retrograde open mesenteric stenting
offers an efficient alternative for emergent superior mesen-
teric artery revascularization in cases of arterial occlusive
acute mesenteric ischemia. It avoids many of the problems
associated with emergent mesenteric bypass. At the same
time, because it is combined with open laparotomy, it
incorporates the essential surgical principles of sepsis con-
trol. Like other forms of mesenteric stenting, however, it
seems to have a high rate of restenosis that requires close
duplex surveillance to determine the need for secondary
intervention. Further study and development of this new
hybrid technique is warranted.
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